Mead Christopher E sold $900K of AJG

Mead Christopher E (VICE PRESIDENT) sold 3,500 shares of Arthur J. Gallagher & Co. (AJG) at $257.02 ($0.90M total) on 2026-08-19.

Original reporting
SEC EDGAR · Mead Christopher E
Published Aug 20, 2026, 11:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 11:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AJG
Neutral
medium confidence
Mentioned
$AJG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AJGNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move AJG's stock, but it adds to the flow of insider activity data.

02

Market read

Primary insider sale filing; low material impact on AJG's price.

03

What to watch

Potential upcoming compensation grant or stock option exercise that may offset the sale.

Relevance 5/10Novelty 4/10Timing: filing disclosed after market close on 2026‑08‑20

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence.

Company-level read

Ticker impact

$AJGNeutralMedium confidence
Context

Vice President Mead Christopher E sold 3,500 shares for $899,587 on 2026-08-19, reducing his holding to 22,223 shares.

Expected impact

Minimal short‑term price pressure; likely absorbed without noticeable move.

Evidence & confidence

The transaction is a primary Form 4 filing, but the dollar amount (<$1 M) and the insider's role (VP) suggest limited market impact.

Market effects

None; insurance brokerage sector unchanged.

No regional effect; transaction is company‑specific.

Negligible; isolated insider sale.

Counterpoint

The sale could be unrelated to company outlook; insiders often diversify holdings.

Key entities

  • Arthur J. Gallagher & Co.

    Insurance brokerage and risk management firm.

  • Mead Christopher E

    Vice President at AJG who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AJGMed

Why is Arthur J Gallagher stock sliding today?

Arthur J. Gallagher & Co. (AJG) stock fell 0.7% in pre-market trading after BMO Capital and Citi downgraded it to Market Perform and Neutral, respectively, citing valuation concerns. Both firms raised their price targets, with Citi setting it at $300. The stock trades near its 52-week high of $281.53. Insider selling and a risk-averse market also contributed to the decline. Jefferies and Wells Fargo maintained bullish outlooks with higher targets.

$AJGMed

BMO downgrades Arthur J. Gallagher stock rating on valuation

BMO downgraded Arthur J. Gallagher (NYSE:AJG) to Market Perform, raising its price target to $295. The firm cited valuation and AI-related market pressures. AJG's Q3 2026 earnings showed a revenue miss but a 25% net earnings growth. Analysts from Goldman Sachs and Keefe, Bruyette & Woods maintained positive outlooks with targets of $296 and $275, respectively.

$AJGMedAI 8/10

Arthur J. Gallagher & Co (AJG) (Q3 2026) Earnings Call Highlights: 26 Straight Quarters

Arthur J. Gallagher & Co reported Q3 2026 revenue growth of 18%, with net earnings and adjusted EBITDAC up 25%. Brokerage revenues rose 19%, while Risk Management grew 14%. M&A pipeline includes 30 term sheets for $300M in annualized revenue. Challenges include property premium declines and slower Employee Benefits growth. Management expects steady margin expansion and synergies from AssuredPartners.

$AJGMed

Goldman Sachs reiterates Arthur J. Gallagher stock rating on in-line Q3 results

Goldman Sachs maintained a Buy rating and $296 price target on Arthur J. Gallagher (AJG) after Q3 results. Adjusted EPS matched estimates at $3.00, but revenue missed expectations. Goldman lowered 2027 Brokerage growth estimate to 4.5% and adjusted revenue expectations. AJG's stock trades near its 52-week high with a P/E ratio of 44.58. Keefe, Bruyette & Woods raised its price target to $275, citing higher adjusted EBITDAC margins.

$AJGMed

Gallagher’s 5% organic growth looks modest - until you compare it with the competition

Arthur J. Gallagher & Co. reported 5% organic growth in Q3, with revenues of $3.93B and adjusted EPS of $3.00. CEO J. Patrick Gallagher Jr. highlighted the strength of their diversified model. Compared to peers, Gallagher's growth appears modest, but its focus on broking may be advantageous in a softening market. The company completed five acquisitions in Q3, adding $102M in annualized revenues.